Crosstalk between the innate immune system and selective autophagy in hepatitis B virus infection

Autophagy. 2022 Aug;18(8):2006-2007. doi: 10.1080/15548627.2022.2059747. Epub 2022 Apr 5.

Abstract

Although the involvement of macroautophagy/autophagy in hepatitis B virus (HBV) infection has become clearer recently, whether selective autophagy plays an important role in suppressing HBV remains uncertain. We recently found that LGALS9 (galectin 9) is an interferon (IFN)-inducible protein involved in the suppression of HBV replication. Expression of LGALS9 in HBV-infected cells causes the formation of cytoplasmic puncta that degrade the HBV core protein (HBc) in conjunction with RSAD2/viperin, another IFN-inducible protein. LGALS9 binds to HBc via RSAD2 and promotes the autoubiquitination of RNF13 (ring finger protein 13) to recruit SQSTM1/p62, resulting in the formation of LC3-positive autophagosomes that degrade HBc. Both LGALS9 and RSAD2 are encoded by IFN-stimulated genes that act synergistically to induce HBc proteolysis in HBV-infected hepatocytes in an IFN-dependent manner. These results reveal a crosstalk mechanism between the innate immune system and selective autophagy during viral infection.

Keywords: BRET; hepatitis B virus; interferon; selective autophagy; xenophagy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Autophagy
  • Hepatitis B virus*
  • Hepatitis B*
  • Hepatocytes
  • Humans
  • Immune System
  • Macroautophagy
  • Virus Replication

Grants and funding

This work was supported in part by AMED under Grant Number JP21fk0310103 to AR and JP21fk0310104 to KM.